TransCode Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TransCode Therapeutics generated cash of -$18,074,535, which is less than the previous year. Cash used in financing activities reached the amount of $15,909,324 last year. Net change in cash is therefore -$2,200,820.
Cash Flow
| 2019 | -508.50K | 0 | 500K |
|---|---|---|---|
| 2020 | -492.97K | 0 | 1.11M |
| 2021 | -5.26M | -251.82K | 25.51M |
| 2022 | -15.76M | -100.91K | 5.98K |
| 2023 | -18.07M | -35.60K | 15.90M |
RNAZ Cash Flow Statement (2019 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 4.96M | 20.82M | 828.01K | 204.47K | 212.97K |
Operating activities | |||||
Net income | -18.54M | -17.56M | -6.84M | -2.34M | -607.21K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 516.74K | 98.60K | 42.47K | 0 | 0 |
Stock-based compensation expense | 1.03M | 395.32K | 185.99K | 45.44K | 1.39K |
| Deferred income tax benefit | 1.03M | 395.32K | 185.99K | 45.44K | 1.39K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 360.22K | -360.22K | 0 | 0 | 0 |
Inventories | 0 | 360.22K | 0 | 0 | 0 |
Accounts payable | -1.29M | 1.84M | 2.28M | 191.25K | -54.74K |
Cash generated by operating activities | -18.07M | -15.76M | -5.26M | -492.97K | -508.50K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -35.60K | -100.91K | -254.82K | 0 | 0 |
Acquisitions Net | 0 | 0 | 3K | 0 | 0 |
Cash generated by investing activities | -35.60K | -100.91K | -251.82K | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 15.90M | 5.98M | 26.33M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.11M | 500K |
Cash used in financing activities | 15.90M | 5.98K | 25.51M | 1.11M | 500K |
Net Change In Cash | -2.20M | -15.85M | 19.99M | 623.54K | -8.50K |
Cash at end of period | 2.76M | 4.96M | 20.82M | 828.01K | 204.47K |
| Data source | Data source | Data source |